Professor Collins' 'random' path to medical statistics took him across three continents, to the Presidential inaugural ball of a certain peanut farmer, and even to knighthood.

Oxygen therapy in stroke, physical activity, hospital rankings, MRI labeling of cardiac devices, and PFO closure are discussed in this week's podcast.

PCSK9 drugs and diabetes, allegations against St Jude Medical, trends in carotid interventions, food as medicine, and death with dignity are discussed by Dr John Mandrola in this week's podcast.

Drs Jolly and Granger discuss three trials presented at ESC 2017 that are making waves in thrombocardiology.

PFO closure for recurrent stroke prevention, hormone replacement in women, DAPT, obesity, and fentanyl are discussed in this week's podcast.

Dr Jolly leads a roundtable discussion on the very low LDL-C subanalysis from FOURIER, the PURE nutrition study, and REVEAL.

CETP inhibition, stroke deaths, BP goals, NSAIDs, and surgical left atrial appendage closure are the topics discussed by Dr Mandrola in this week's podcast.

Modulating the inflammatory cascade was beneficial in the secondary prevention of cardiovascular disease with some surprising off-target effects. Drs Yancy and Byrne review the implications of CANTOS.

Dr Mandrola interviews the PI of CANTOS, presented at the European Society of Cardiology congress, who's spent his career researching the anti-inflammatory hypothesis of cardiovascular disease.